In 2023, the trade exchange (includes international purchases and sales) of Glycosides, Natural or Reproduced by Synthesis, their Salts, Ethers, Esters and other Derivatives was US$57.7M.
In 2023, the states with the most international sales in Glycosides, Natural or Reproduced by Synthesis, their Salts, Ethers, Esters and other Derivatives were Ciudad de México (US$1.83M) and Estado de México (US$353k).
The states with the most international purchases in 2023 were Ciudad de México (US$19.4M), Estado de México (US$16.8M), Jalisco (US$6.19M), Nuevo León (US$5.32M), and Querétaro (US$2.71M).
In 2023, the main commercial destinations of Glycosides, Natural or Reproduced by Synthesis, their Salts, Ethers, Esters and other Derivatives were Costa Rica (US$842k), United States (US$715k), Brazil (US$285k), France (US$170k), and Chile (US$86.4k).
The main commercial origins of Glycosides, Natural or Reproduced by Synthesis, their Salts, Ethers, Esters and other Derivatives in 2023 were China (US$14.4M), Spain (US$12.6M), France (US$9.82M), Malaysia (US$6.48M), and South Korea (US$4.2M).
In the global context, the main exporting countries of Glycosides, Natural or Reproduced by Synthesis, their Salts, Ethers, Esters and other Derivatives in 2022 were China (US$1.06B), France (US$165M), and Spain (US$103M). In the same year, the main importing countries of Glycosides, Natural or Reproduced by Synthesis, their Salts, Ethers, Esters and other Derivatives were United States (US$431M), Hong Kong (US$158M), and India (US$129M).